NP5.DE · NEWRON PHARMACEUT. EO-,20
Germany · RS rating 2 · As of 2026-10-14
| Price | 8.52 EUR |
|---|---|
| 1-day change | +6.5% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 3 / 4 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 5 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +74.2% |
| Market cap (USD) | $192.9M |